Ayr Wellness Inc. (CSE:AYR.A)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmaceuticals	463.63M	463.63M	421.44M	357.61M	155.11M
Total	463.63M	463.63M	421.44M	357.61M	155.11M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
United States	463.63M	463.63M	421.44M	357.61M	155.11M
Total	463.63M	463.63M	421.44M	357.61M	155.11M

Data Source: S&P Global Market Intelligence Last updated: Sep 12, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 8, 2026

Data Sources Report a data error